• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    亨

    亨利·蒙多尔大学

    Hôpitaux Universitaires Henri-Mondor,Assistance Publique – Hôpitaux de Paris
    院校EST. 1969
    3,072论文总数
    7.3万引用总数

    论文量&引用量时间轴

    机构学者

    论文(3072)

    年份
    起
    –
    止
    排序
    1Woven Endobridge Device for Ruptured Vs. Unruptured Aneurysms: Insights from the WorldWideWEB Study
    Franja Dugar,Muhammed Amir Essibayi, Hamza Adel Salim,Basel Musmar,Nimer Adeeb, Mahmoud Dibas, Yan-Lin Li,Oktay Algin,Sherief Ghozy, Sovann V. Lay,Adrien Guenego,Leonardo Renieri,

    Although the Woven EndoBridge (WEB) device is increasingly used for the treatment of wide-neck intracranial aneurysms, including in the acute rupture setting, comparative evidence assessing the impact of rupture status remains limited. This study compared angiographic, safety, and clinical outcomes between ruptured and unruptured intracranial aneurysms treated with WEB. We conducted a retrospective analysis of prospectively collected data from the multicenter cohort registry WorldWideWEB, including consecutive adult patients with intracranial aneurysms treated with the WEB. Patients were stratified into groups of ruptured and unruptured aneurysms. Propensity score matching was used to balance baseline characteristics between both groups. Retreatment rate was the primary outcome. Secondary outcomes included mRS, safety events (thromboembolic complications) and angiographic outcomes (periprocedurally and last follow-up). Among 1,220 patients, 342 (28.0

    2026Neuroradiology(2026)引用:21
    引用
    AI阅读
    加入学术空间
    2Real-World Safety Profile of Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: a Multinational Multicenter Study.
    Bluyé DeMessie, Alireza Karandish,Muhammed Amir Essibayi, Hamza Adel Salim,Deepak Khatri, Neil Haranhalli, Amanda Baker,Richard Zampolin, Allan L. Brook,Seon-Kyu Lee,Nimer Adeeb,Dhairya A. Lakhani,

    Middle meningeal artery embolization (MMAE) has emerged as a treatment for chronic subdural hematoma (cSDH), but comprehensive real-world safety data remain limited. We performed a multicenter retrospective analysis of 1781 consecutive patients undergoing MMAE for cSDH (2019–2025). The primary outcome was any procedure-related complication within 30 days. Inverse probability of treatment weighting (IPTW) assessed the association between technical success and complications, adjusting for demographic, clinical, and procedural confounders. Mean age was 72.8 ± 12.4 years; 68.1

    2026Clinical Neuroradiology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    3Open-label Treatment Extension of Ruxolitinib Cream in Vitiligo: Findings from the Topical Ruxolitinib Evaluation in Vitiligo (True-V) Long-Term Extension Phase III Study.
    John E Harris,Kim Papp,Khaled Ezzedine,Michael Sebastian,Amit G Pandya,Julien Seneschal, Mark Amster, Maryam Shayesteh Alam,Seth B Forman,Jacek Zdybski, Anthony Nuara,Deanna Kornacki,

    We present data from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension (LTE) study evaluating repigmentation outcomes with continued 1.5% ruxolitinib cream treatment in patients who did not achieve near-complete facial repigmentation in TRuE-V1/TRuE-V2. Among patients in the TRuE-V1/TRuE-V2 trials who applied ruxolitinib cream from day 1, approximately 66% achieved F-VASI 75 (indicative of treatment success) at week 104, increasing from nearly 31% at week 52 (TRuE-V LTE baseline); similar repigmentation improvements were reported in patients who switched from vehicle to ruxolitinib cream after TRuE-V1/TRuE-V2 at week 24, albeit with lower overall response rates due to the shorter duration of ruxolitinib cream application. These findings indicate that continued ruxolitinib cream treatment allows further repigmentation in many patients.

    2026The British journal of dermatology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    4Factors Associated with Short Hospital Stay after Combined Middle Meningeal Artery Embolization and Surgical Evacuation for Chronic Subdural Hematoma
    Anthony Terraciano, Bluyé DeMessie,Muhammed Amir Essibayi,Abdulrhman Alsalama,Khushal Gupta, Hamza Adel Salim,Alireza Karandish,Nimer Adeeb,Dhairya A. Lakhani,Yan-Lin Li,Diego Alejandro Ortega,Joseph Carnevale,

    Middle meningeal artery embolization (MMAE) plus surgical evacuation is increasingly used for chronic subdural hematoma (cSDH), but predictors of length of stay (LOS) and outcomes associated with early discharge remain unclear. We performed a multicenter MESH Registry study (2019–2024) of patients undergoing MMAE and surgical evacuation for symptomatic cSDH. Short-stay discharge was defined as LOS ≤4 days. Predictors were identified using multivariable logistic regression. The 90-day composite adverse event was defined as cSDH recurrence requiring intervention, reintervention (repeat MMAE or surgical evacuation), or 30-day all-cause readmission. Safety was assessed using adjusted logistic regression, generalized estimating equations (GEE), inverse probability of treatment weighting (IPTW), and multiple imputation by chained equations (MICE). Among 647 patients (mean age 72.6 years; 74.0

    2026Clinical Neuroradiology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Alexithymia in Patients with Posttraumatic Stress Disorder: A Meta-Analysis.
    Maryline Couette, Vanessa Cagnone, Guillaume Turc, Samantha Johnson,Stephane Mouchabac,Florian Ferreri

    OBJECTIVES:Posttraumatic stress disorder (PTSD) is a psychiatric condition resulting from one or more traumatic events, characterized by behavioural and emotional disturbances. Alexithymia, the difficulty in identifying and describing internal emotions, is a significant comorbidity that can exacerbate PTSD symptoms but is often understated. This study aimed to estimate the prevalence of alexithymia in PTSD patients and explore associated factors and potential moderators. METHODS:We conducted a systematic review of the literature, querying three databases for studies on alexithymia in adults with PTSD. Meta-analyses were performed to assess the prevalence of alexithymia and explore its moderators. RESULTS:Thirty-six studies met the inclusion criteria. The pooled prevalence of alexithymia in PTSD patients was 53% (95% CI: 42-65%). The mean TAS score indicated a possible threshold for alexithymia (56.12, 95% CI: 50.77-61.48), with a significant difference in alexithymia scores between PTSD patients and trauma-exposed controls (SMD: 0.78, 95% CI: 0.22-1.34). PTSD severity was positively correlated with alexithymia, and alexithymia was significantly associated with dissociative symptoms. CONCLUSIONS:Alexithymia is a frequent and impactful comorbidity in PTSD, complicating its clinical picture and therapeutic management. The introspective difficulties associated with alexithymia hinder the effectiveness of traditional therapies, and its influence on body-related symptoms suggests that integrating Mind-Body approaches may improve treatment outcomes. Given the significant overlap between alexithymia, dissociation, and trauma exposure, a more tailored, nuanced treatment is needed to enhance emotional regulation and self-awareness in PTSD patients.

    2026L'Encephale(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3072 篇论文

    合作机构(100)

    巴黎医院公共援助合作论文 376
    法国国家健康与医学研究院合作论文 116
    索邦大学合作论文 98
    巴黎大学合作论文 94
    Centre Hospitalier Universitaire de Rennes合作论文 94
    大学医院(新泽西州纽瓦克)合作论文 71
    里昂市民临终关怀院合作论文 64
    Centre Hospitalier Universitaire de Nantes合作论文 60
    Pitié-Salpêtrière Hospital,Assistance Publique – Hôpitaux de Paris合作论文 60
    巴黎东部克雷泰尔大学合作论文 56

    机构统计